VIVIER CANADA INC has a total of 25 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2001. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are GUIZHOU HOLY PHARMACEUTICAL CO LTD, KANSAI KOUSO KK and KOSEI SANGYO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 8 | |
#2 | United States | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Australia | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Specific use of cosmetics | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Vivier Ghislain | 21 |
#2 | Costa Anthony | 8 |
#3 | Tsunetsugu Shuichi | 3 |
#4 | Inaoka Satoshi | 2 |
#5 | Inaoka Ken | 1 |
#6 | Ichitsubo Tatsuya | 1 |
#7 | Anno Rikako | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020163942A1 | High concentration vitamin c topical compositions and method of making same | |
WO2019232644A1 | Sterile topical saline putrescine formulation and uses thereof | |
CA3067905A1 | Putrescine topical formulations | |
US2019314299A1 | Putrescine topical barrier formulation | |
US2019298688A1 | Putrescine slow-release topical formulations | |
CA2508095A1 | Preparation for external use on skin | |
CA2508094A1 | Composition for accelerating collagen synthesis | |
WO0219972A2 | Stabilized ascorbic acid solutions |